Yichang Hec Changjiang Pharmaceutical Co. Ltd. announced securities dealings under the Hong Kong Code on Takeovers and Mergers. On May 27, 2025, CICC Financial Trading Limited executed transactions involving Delta 1 products and ordinary shares. The dealings were linked to unsolicited client-driven orders, involving the sale and purchase of 342,800 shares. CICC Financial Trading Limited is an exempt principal trader connected with the Offeror and is owned by China International Capital Corporation Limited.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.